Table 5. Rheumatological work up of the patient during the initial encounter and 12 week follow up.
| Rheumatological workup continued | Value initial | Value at 12 weeks |
| Antinuclear antibody (ANA) screen | Positive | N/A |
| ANA homogenous pattern | 1:160 | N/A |
| ANA nucleolar pattern | 1:80 | N/A |
| Lupus anticoagulant (LA) | 1.39 ratio | 1.50 ratio |
| Anticardiolipin antibody (aCL) IgM | >150 MPL U/mL | >150 MPL U/mL |
| aCL IgA | <9 APL U/mL | <9 APL U/mL |
| aCL IgG | <9 GPL U/mL | <9 GPL U/mL |
| Anti-β2glycoprotein-1 antibodies | <9 GPI units | <9 GPI units |